The relationship between the urokinase-type plasminogen activator gene Pro141Leu polymorphism and patients with prostate cancer
This is the first study to investigate the association between the rs2227564 polymorphism and prostate cancer. Although the urokinase-type plasminogen activator gene Pro141Leu polymorphism has been reported to be a risk factor for some cancers, our findings suggest that the urokinase-type plasminogen activator gene Pro141Leu polymorphism is not an important genetic risk factor for prostate cancer.
Authors
- Murat Bozlu (ORCID: https://orcid.org/0000-0002-8624-0149)
- Cemil Gülüm (ORCID: https://orcid.org/0000-0002-0535-9966)
- Rojda Tanrıverdi (ORCID: https://orcid.org/0000-0002-7004-790X)
- Pelin Eroğlu (ORCID: https://orcid.org/0000-0002-6462-6841)
Institutions
- Mersin Üniversitesi (TR)
Publication Details
- Journal
- Revista da Associação Médica Brasileira
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1590/1806-9282.20250097
- Primary Topic
- Protease and Inhibitor Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00